Alphamab Oncology (3NK)
Market Closed
11 Aug, 20:00
XFRA 
€
0. 93
+0.01
+1.6483%
€
1.24B Market Cap
- P/E Ratio
- Div Yield
2,600 Volume
- Eps
€ 0.91
Previous Close Want to track 3NK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3NK Earnings Reports FAQ
What is the earnings per share (EPS) for 3NK?
EPS data for 3NK is currently not available, as Alphamab Oncology has not reported recent earnings.
What is the company's earnings growth rate?
Alphamab Oncology has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Alphamab Oncology has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Alphamab Oncology are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 3NK at this time, as Alphamab Oncology has no recent EPS data to calculate it.
